Interestingly, elevated lysoPC levels have been demonstrated in NASH patients and functionally linked to hepatocyte stress, lipo-apoptosis and insulin resistance [[36], [37], [38]]. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.